PPT Slide

Oral vs. IV therapy in CAP

CAP 3: +/- same causative organisms as CAP 2, but :

• More co-morbidities

• Higher mortality / morbidity

• More frequent extra-pulmonary spread

• More frequent prior AB use

• More frequent resistant strains

High AB tissue- and serum- concentrations needed

? intravenous therapy

Previous slide

Next slide

Back to first slide

View graphic version